Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.95% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.98% |
| 4 | Financials | 6.14% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FORG
5051
CALL
DELISTED
ForgeRock, Inc.
FORG
| $218K | ﹤0.01% |
10,600
-1,501,800
| -99% | -$30.5M |
|
5052
TaskUs
TASK
$769M
| $217K | ﹤0.01% |
15,000
-127,567
| -89% | -$2.22M |
|
5053
Tyra Biosciences
TYRA
$1.49B
| $217K | ﹤0.01% |
+13,475
| New | +$160K |
|
|
FFNW
5054
DELISTED
First Financial Northwest, Inc
FFNW
| $217K | ﹤0.01% |
17,007
+5,903
| +53% | +$86.5K |
|
5055
Q32 Bio
QTTB
$447M
| $216K | ﹤0.01% |
11,649
-1,740
| -13% | -$43.3K |
|
5056
CALL
Royal Caribbean
RCL
$74.7B
| $215K | ﹤0.01% |
3,300
-71,500
| -96% | -$4.72M |
|
5057
Cushman & Wakefield Ltd
CWK
$3.31B
| $213K | ﹤0.01% |
20,220
-29,218
| -59% | -$376K |
|
|
JWN
5058
PUT
DELISTED
Nordstrom
JWN
| $213K | ﹤0.01% |
+13,100
| New | +$245K |
|
|
GDEV
5059
DELISTED
Nexters Inc. Ordinary Shares
GDEV
| $213K | ﹤0.01% |
31,116
-15,403
| -33% | -$105K |
|
5060
AstraZeneca
AZN
$252B
| $212K | ﹤0.01% |
1,528
-314,003
| -100% | -$42.2M |
|
5061
CALL
Affirm
AFRM
$26B
| $211K | ﹤0.01% |
+18,700
| New | +$236K |
|
5062
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $211K | ﹤0.01% |
4,416
-87,086
| -95% | -$4.1M |
|
5063
PUT
TE Connectivity
TEL
$58.7B
| $210K | ﹤0.01% |
1,600
-47,800
| -97% | -$6.05M |
|
5064
CALL
Upstart Holdings
UPST
$2.83B
| $210K | ﹤0.01% |
+13,200
| New | +$222K |
|
|
SRT
5065
DELISTED
Startek Inc.
SRT
| $210K | ﹤0.01% |
50,905
-31,794
| -38% | -$126K |
|
5066
Alto Ingredients
ALTO
$316M
| $209K | ﹤0.01% |
139,262
-615,137
| -82% | -$1.68M |
|
|
BGB
5067
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
| $209K | ﹤0.01% |
+19,611
| New | +$214K |
|
|
PTN
5068
Palatin Technologies
PTN
$18.6M
| $209K | ﹤0.01% |
1,520
+600
| +65% | +$99.7K |
|
5069
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
| $209K | ﹤0.01% |
8,425
-967,814
| -99% | -$23.9M |
|
5070
CALL
Xcel Energy
XEL
$47.8B
| $209K | ﹤0.01% |
+3,100
| New | +$209K |
|
|
5071
PUT
Xcel Energy
XEL
$47.8B
| $209K | ﹤0.01% |
+3,100
| New | +$209K |
|
|
SYRS
5072
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $209K | ﹤0.01% |
78,336
-13,137
| -14% | -$50.9K |
|
5073
CALL
CONMED
CNMD
$1.5B
| $208K | ﹤0.01% |
2,000
-3,000
| -60% | -$290K |
|
5074
Cogent Biosciences
COGT
$6.02B
| $208K | ﹤0.01% |
19,242
-180,940
| -90% | -$2.31M |
|
5075
PUT
Arbor Realty Trust
ABR
$944M
| $207K | ﹤0.01% |
18,000
| – | – |
|
Similar funds
Israel Englander's Q1 2023 Portfolio in Review
As of Q1 2023, Israel Englander held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Israel Englander withdrew a net $7.42B in Q1 2023, closing 1,206 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Israel Englander opened a new position in Warner Bros worth $96.9M.
- Israel Englander's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Israel Englander added most to Linde in Q1 2023, an estimated $374M increase.
- Israel Englander's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Israel Englander fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Israel Englander's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Israel Englander opened 987 new positions and closed 1,206 in Q1 2023.
- Israel Englander's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.